Explore effective treatment strategies and multidisciplinary approaches for managing chronic graft-versus-host disease post-allogeneic stem cell transplant.
Optimizing Treatment Sequencing in Chronic Graft-versus-Host Disease After Allogenic Transplant
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing skin and joint symptoms, requiring ongoing steroid management.
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing complex symptoms and treatment challenges. Discover her journey and management strategies.
Explore the treatment options for chronic graft versus host disease patients after use of second-line therapy.
Explore the latest advancements in treating sclerotic skin disease and pulmonary involvement with effective therapies like axetilimab and baramitsode.
Discover the latest insights on axatilimab and belimumab for chronic GVHD, highlighting efficacy, safety, and innovative treatment combinations.